Allianz Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.87M Sell
14,196
-1,890
-12% -$251K ﹤0.01% 1580
2025
Q4
$2.28M Buy
16,086
+1,118
+7% +$162K ﹤0.01% 1498
2025
Q3
$2.1M Sell
14,968
-1,584
-10% -$215K ﹤0.01% 1478
2025
Q2
$2.08M Sell
16,552
-8,486
-34% -$973K ﹤0.01% 1460
2025
Q1
$2.77M Sell
25,038
-3,380
-12% -$428K ﹤0.01% 1360
2024
Q4
$3.88M Buy
28,418
+69
+0.2% +$8.53K 0.01% 1158
2024
Q3
$3.27M Buy
28,349
+6,676
+31% +$915K 0.01% 1231
2024
Q2
$2.98M Sell
21,673
-5,795
-21% -$795K ﹤0.01% 1162
2024
Q1
$3.79M Sell
27,468
-2,140
-7% -$292K 0.01% 967
2023
Q4
$3.9M Sell
29,608
-52,518
-64% -$6.05M 0.01% 1045
2023
Q3
$9.24M Sell
82,126
-1,746
-2% -$184K 0.02% 747
2023
Q2
$7.91M Sell
83,872
-157,121
-65% -$15.4M 0.02% 720
2023
Q1
$24.4M Sell
240,993
-9,936
-4% -$1.03M 0.05% 427
2022
Q4
$30M Buy
250,929
+73,619
+42% +$8.62M 0.07% 356
2022
Q3
$18.8M Sell
177,310
-68,354
-28% -$6.94M 0.04% 484
2022
Q2
$23.9M Sell
245,664
-20,358
-8% -$1.88M 0.02% 621
2022
Q1
$24.9M Buy
266,022
+67,248
+34% +$5.7M 0.02% 674
2021
Q4
$16.9M Sell
198,774
-22,653
-10% -$2.08M 0.01% 824
2021
Q3
$21.2M Buy
221,427
+58,850
+36% +$5.56M 0.02% 724
2021
Q2
$15.8M Buy
162,577
+84,096
+107% +$8.06M 0.01% 709
2021
Q1
$7.63M Buy
78,481
+906
+1% +$95K 0.01% 916
2020
Q4
$7.44M Buy
77,575
+26,844
+53% +$2.59M 0.01% 938
2020
Q3
$4.88M Buy
50,731
+10,046
+25% +$1.16M 0.01% 990
2020
Q2
$4.96M Sell
40,685
-3,172
-7% -$351K 0.01% 1220
2020
Q1
$3.8M Sell
43,857
-12,239
-22% -$1.2M 0.01% 1276
2019
Q4
$6.03M Sell
56,096
-57,135
-50% -$5.98M 0.01% 1396
2019
Q3
$10.2M Sell
113,231
-44,625
-28% -$4.17M 0.01% 1102
2019
Q2
$13.3M Sell
157,856
-6,749
-4% -$554K 0.01% 1023
2019
Q1
$14.5M Sell
164,605
-121,765
-43% -$10.2M 0.02% 916
2018
Q4
$20.4M Sell
286,370
-81,536
-22% -$7.81M 0.02% 702
2018
Q3
$45.2M Sell
367,906
-1,663
-0.4% -$189K 0.05% 476
2018
Q2
$36.3M Sell
369,569
-26,531
-7% -$2.37M 0.04% 549
2018
Q1
$32.8M Buy
396,100
+45,775
+13% +$3.87M 0.04% 614
2017
Q4
$27.2M Buy
350,325
+310,214
+773% +$21.2M 0.03% 837
2017
Q3
$2.46M Buy
40,111
+75
+0.2% +$3.96K ﹤0.01% 1932
2017
Q2
$1.85M Buy
+40,036
New +$1.94M ﹤0.01% 2016
2017
Q1
Sell
-224,869
Closed -$8.7M 2640
2016
Q4
$8.7M Sell
224,869
-3,876
-2% -$175K 0.01% 1421
2016
Q3
$11.5M Sell
228,745
-64,431
-22% -$3.21M 0.01% 1257
2016
Q2
$13.3M Sell
293,176
-11,231
-4% -$517K 0.02% 1102
2016
Q1
$12M Buy
304,407
+95,767
+46% +$3.8M 0.02% 1039
2015
Q4
$11.8M Buy
208,640
+18,600
+10% +$945K 0.01% 988
2015
Q3
$7.56M Buy
190,040
+26,165
+16% +$1.26M 0.01% 1105
2015
Q2
$7.83M Sell
163,875
-103,664
-39% -$4.4M 0.01% 1208
2015
Q1
$10.6M Sell
267,539
-192,881
-42% -$6.9M 0.01% 933
2014
Q4
$10.3M Buy
460,420
+205,210
+80% +$3.89M 0.01% 951
2014
Q3
$4M Sell
255,210
-23,000
-8% -$344K 0.01% 1170
2014
Q2
$4.13M Sell
278,210
-3,190
-1% -$45K 0.01% 987
2014
Q1
$4.53M Buy
281,400
+55,000
+24% +$941K 0.01% 980
2013
Q4
$2.12M Hold
226,400
﹤0.01% 1195
2013
Q3
$2.56M Sell
226,400
-205,100
-48% -$2.82M ﹤0.01% 1121
2013
Q2
$5.77M Buy
+431,500
New +$5.3M 0.01% 843

Other funds holding NBIX